| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $597,733,943 ) (Continued on the next page) |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R35HL145000 | Engineering biophysical microtechnologies for hematologic applications in health and disease | 000 | 4 | NIH | 2/25/2022 | $692,638 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH115174 | The effects of pregnancy on post traumatic symptoms and fear physiology in traumatized African American women | 000 | 5 | NIH | 6/14/2022 | $654,673 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | F32ES031827 | Mechanisms of bisphenol A induced epigenomic alterations in the mammalian germline | 001 | 3 | NIH | 6/16/2022 | $2 |
| | 2022 | 2022 | Emory University | 1599 Clifton Road NE, 4th Floor | Atlanta | GA | 30322-4250 | DEKALB | USA | NU14GH001238 | Advancing National Public Health Institutes Globally to strengthen public health systems to enable better prevention, detection, and respondto public health threats. | 00 | 4 | CDC | 7/21/2022 | $100,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | F32ES031827 | Mechanisms of bisphenol A induced epigenomic alterations in the mammalian germline | 000 | 3 | NIH | 4/22/2022 | $78,548 |
| | 2022 | 2022 | Emory University | 1599 Clifton Road NE, 4th Floor | Atlanta | GA | 30322-4250 | DEKALB | USA | NU14GH001238 | Advancing National Public Health Institutes Globally to strengthen public health systems to enable better prevention, detection, and respondto public health threats. | 00 | 4 | CDC | 7/21/2022 | $27,800 |
| | 2022 | 2022 | Emory University | 1599 Clifton Road NE, 4th Floor | Atlanta | GA | 30322-4250 | DEKALB | USA | NU14GH001238 | Advancing National Public Health Institutes Globally to strengthen public health systems to enable better prevention, detection, and respondto public health threats. | 00 | 4 | CDC | 7/21/2022 | $285,000 |
| | 2022 | 2022 | Emory University | 1599 Clifton Road NE, 4th Floor | Atlanta | GA | 30322-4250 | DEKALB | USA | NU14GH001238 | Advancing National Public Health Institutes Globally to strengthen public health systems to enable better prevention, detection, and respondto public health threats. | 00 | 4 | CDC | 7/21/2022 | $100,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01DK120814 | Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program | 002 | 5 | NIH | 7/21/2022 | $386,877 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01DK120814 | Putting Telehealth to the Test: An Evaluation of the Use of Telehealth to Increase the Population-Level Impact of an Employer-Based Diabetes Prevention Program | 003 | 5 | NIH | 9/14/2022 | $371,054 |
| | 2022 | 2022 | Emory University | 1599 Clifton Road NE, 4th Floor | Atlanta | GA | 30322-4250 | DEKALB | USA | NU14GH001238 | Advancing National Public Health Institutes Globally to strengthen public health systems to enable better prevention, detection, and respondto public health threats. | 00 | 4 | CDC | 7/21/2022 | $255,957 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R37AI076119 | Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV | 000 | 14 | NIH | 1/13/2022 | $347,480 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01HD094716 | Self-derivation of new factual knowledge through memory integration in development | 000 | 4 | NIH | 6/13/2022 | $317,371 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R37AI076119 | Ultrapotent Inhibitors of Wild-type and Multi-drug Resistant HIV | 000 | 14 | NIH | 1/13/2022 | $122,719 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01GM138544 | Post-transcriptional mechanisms of centrosome regulation | 000 | 3 | NIH | 6/17/2022 | $323,819 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01GM138544 | Post-transcriptional mechanisms of centrosome regulation | 001 | 3 | NIH | 7/19/2022 | $18,780 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AI152516 | CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity | 001 | 3 | NIH | 8/2/2022 | $45,144 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AI152516 | CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity | 000 | 3 | NIH | 2/11/2022 | $390,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01AR076153 | Neuroplastic Mechanisms for Acquisition and Transfer of Injury-Resistant Movement Patterns Assessed in VR Simulated Sport | 000 | 3 | NIH | 6/15/2022 | $318,291 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K01HD100588 | Functional Role of Golgi tendon organ feedback in health and disease | 000 | 4 | NIH | 8/12/2022 | $129,060 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K08DK111998 | Role of T cells in Uremic Cardiomyopathy | 007 | 4 | NIH | 9/9/2022 | $0 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01DA046197 | Developing the evidence base for overdose policies: a multilevel analysis of NHBS | 000 | 5 | NIH | 2/16/2022 | $538,735 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01DA046197 | Developing the evidence base for overdose policies: a multilevel analysis of NHBS | 001 | 5 | NIH | 3/29/2022 | $59,862 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K08DK111998 | Role of T cells in Uremic Cardiomyopathy | 005 | 4 | NIH | 8/30/2022 | -$54,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K08DK111998 | Role of T cells in Uremic Cardiomyopathy | 002 | 4 | NIH | 2/7/2022 | $54,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R56AG074886 | Neighborhood redlining, economic deprivation, and the breast tumor epigenome: bridging social and molecular epidemiology to address the Black-White breast cancer mortality disparity | 000 | 1 | NIH | 9/22/2022 | $532,975 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21ES034130 | Extreme heat events and fertility: a national study | 000 | 1 | NIH | 4/25/2022 | $208,262 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH126195 | Leveraging 3D bioprinted organoid constructs to pattern and model human brain development | 001 | 2 | NIH | 6/21/2022 | $65,055 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH126195 | Leveraging 3D bioprinted organoid constructs to pattern and model human brain development | 000 | 2 | NIH | 1/13/2022 | $585,483 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | RF1AG079256 | Understanding the functional impacts of A? variants in Alzheimer's disease with human brain organoids | 000 | 1 | NIH | 7/28/2022 | $2,333,853 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | UM1AI164562 | Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) | 001 | 2 | NIH | 4/14/2022 | $166,666 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | UM1AI164562 | Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) | 001 | 2 | NIH | 4/14/2022 | $208,333 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01NS123562 | Shared mechanisms of astrocyte maturation in development and glioblastoma | 000 | 2 | NIH | 6/30/2022 | $392,106 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | UM1AI164562 | Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) | 001 | 2 | NIH | 4/14/2022 | $125,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | UM1AI164562 | Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) | 001 | 2 | NIH | 4/14/2022 | $3,936,426 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | UM1AI164562 | Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) | 002 | 2 | NIH | 7/14/2022 | $609,250 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | UM1AI164562 | Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) | 001 | 2 | NIH | 4/14/2022 | $166,666 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | UM1AI164562 | Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV) | 001 | 2 | NIH | 4/14/2022 | $200,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21MH124200 | A Smartphone Game to Increase Engagement in Care among African Adolescents Living with HIV | 002 | 2 | NIH | 8/2/2022 | $1,000 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R21MH124200 | A Smartphone Game to Increase Engagement in Care among African Adolescents Living with HIV | 002 | 2 | NIH | 8/2/2022 | $177,072 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01ES032140 | Cardiovascular health and exposure to PM2.5 constituents: a multi-cohort study | 001 | 3 | NIH | 7/26/2022 | $551,619 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01GM137011 | Next Generation Glycan Microarray using DNA-coded glycans and Next Generation Sequencing (NGS) | 000 | 3 | NIH | 7/26/2022 | $335,400 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K00ES033033 | Neuron-Astrocyte Interactions in Developmental Lead Exposure | 001 | 4 | NIH | 8/8/2022 | -$78,034 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K00ES033033 | Neuron-Astrocyte Interactions in Developmental Lead Exposure | 001 | 4 | NIH | 8/8/2022 | $78,034 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | D43TW011404 | COllaborative research, implementation, And LEadership training to addresS chronic Conditions across the lifecoursE (COALESCE) | 000 | 4 | NIH | 6/3/2022 | $248,359 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K00ES033033 | Neuron-Astrocyte Interactions in Developmental Lead Exposure | 000 | 4 | NIH | 7/29/2022 | $78,034 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K00ES033033 | Neuron-Astrocyte Interactions in Developmental Lead Exposure | 000 | 4 | NIH | 7/29/2022 | $6,716 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | K24AG062786 | Mid-Career Program for Vascular Contributions to Alzheimer's disease | 000 | 3 | NIH | 2/10/2022 | $183,004 |
| | 2022 | 2022 | EMORY UNIVERSITY | 201 DOWMAN DR | ATLANTA | GA | 30322-1007 | DEKALB | USA | R01MH119251 | Mapping the Infant Brain Developmental Connectome: Temporally Precise Growth Trajectories of Changing Infant Brain Topology | 000 | 3 | NIH | 3/17/2022 | $266,239 |
|
